Pirbenicillin, a New Semisynthetic Penicillin with Broad-Spectrum Activity
Open Access
- 1 April 1976
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 9 (4) , 668-674
- https://doi.org/10.1128/aac.9.4.668
Abstract
Pirbenicillin is a new semisynthetic penicillin which inhibited 67% of isolates of Proteus aeruginosa tested in our laboratory, 93% of P. mirabilis , 31% of Enterobacter spp., 41% of Serratia spp., and 58% of Escherichia coli at a concentration of 6.25 μg/ml. Its activity appeared to be inoculum dependent and it was virtually inactive against 10 7 inocula of P. aeruginosa . It was more active than carbenicillin or ticarcillin, but less active than BL-P1654 against P. aeruginosa . Carbenicillin and ticarcillin appeared to be more active than pirbenicillin against Proteus spp., but pirbenicillin was active against some isolates of Klebsiella spp.Keywords
This publication has 5 references indexed in Scilit:
- The Hemostatic Defect Produced by CarbenicillinNew England Journal of Medicine, 1974
- Ticarcillin Therapy of InfectionsAntimicrobial Agents and Chemotherapy, 1973
- Carbenicillin Therapy for Pseudomonas InfectionsJAMA, 1971
- In vitro studies of semisynthetic alpha-(substituted-ureido) penicillins.1971
- New Semi-synthetic Penicillin active against Pseudomonas pyocyaneaNature, 1967